Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
15/07/2026 01:02
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine July 15 (Reuters) - Taiwan-based contract drugmaker Bora Pharmaceuticals 6472.TW will partner with Insilico Medicine 3696.HK on a collaboration potentially valued at over $2.5 billion if fully implemented, the drug discovery firm said on Wednesday.
(Reporting by Andrew Silver in Shanghai; Editing by Muralikumar Anantharaman)
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7